FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229
K Number: K011166
·
Decision May 10, 2001
Classifications
1
FEI Numbers
24
Registration Numbers
24
Same Product Code
70
Applicant Total
19
Review Days
24
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229
- K Number
- K011166
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 862.3880
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Syva Co., Dade Behring, Inc.
- Date Received
- April 16, 2001
- Decision Date
- May 10, 2001
- Product Code
- KLS
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| KLS | Enzyme Immunoassay, Theophylline | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (KLS), ordered by most recent decision date.
VITROS CHEMISTRY PRODUCTS CAFFN REAGENT KIT AND TDM PERFORMANCE VERIFIERS I, II AND III
FDA 510(k)
FDA Class 2
·Clinical Toxicology
EMIT CAFFEINE ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ROCHE ONLINE THEOPHYLLINE
FDA 510(k)
FDA Class 2
·Clinical Toxicology
RANDOX THEOPHYLLINE
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ACS: 180 AND ADVIA CENTAUR THEOPHYLLINE 2 ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ABBOTT AEROSET THEOPHYLLINE ASSAY AND CALIBRATORS; MODELS 1E09 AND 6E89
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Syva Co., Dade Behring, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K011920 | EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229 | Jul 2, 2001 | Substantially Equivalent |
| K011620 | EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229 | Jun 18, 2001 | Substantially Equivalent |
| K011605 | EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229 | Jun 12, 2001 | Substantially Equivalent |
| K011300 | EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229 | May 17, 2001 | Substantially Equivalent |
| K011306 | EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229 | May 16, 2001 | Substantially Equivalent |
| K011161 | MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229 | May 15, 2001 | Substantially Equivalent |
| K011289 | EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229 | May 15, 2001 | Substantially Equivalent |
| K011163 | MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229 | May 10, 2001 | Substantially Equivalent |
| K011164 | MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229 | May 10, 2001 | Substantially Equivalent |
| K011162 | MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY | May 2, 2001 | Substantially Equivalent |